References
- Dimaras H, Kimani K, Dimba EAO, et al. Retinoblastoma. Lancet. 2012;379(9824):1436–1446. doi:10.1016/S0140-6736(11)61137-9.
- Wong JR, Tucker MA, Kleinerman RA, Devesa SS. Retinoblastoma incidence patterns in the US surveillance, epidemiology, and end results program. JAMA Ophthalmol. 2014;132(4):478–483. doi:10.1001/jamaophthalmol.2013.8001.
- Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res. 2019;97(1):29–44. doi:10.1002/jnr.24213.
- Wong ES, Choy RW, Zhang Y, et al. Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health. 2022;10(3):e380–e389. doi:10.1016/S2214-109X(21)00555-6.
- Singh G, Daniels AB. Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries. Semin Ophthalmol. 2016;31(4):310–316. doi:10.3109/08820538.2016.1154177.
- Cheung R. Impact of socioeconomic disparities on cause-specific survival of retinoblastoma. Mol Clin Oncol. 2013;1(3):535–540. doi:10.3892/mco.2013.83.
- Rajeshuni N, Whittemore AS, Ludwig CA, Mruthyunjaya P, Moshfeghi DM. Racial, ethnic, and socioeconomic disparities in retinoblastoma enucleation: a population-based study, SEER 18 2000–2014. Am J Ophthalmol. 2019;207:215–223. doi:10.1016/j.ajo.2019.04.015.
- Truong B, Green AL, Friedrich P, Ribeiro KB, Rodriguez-Galindo C. Ethnic, racial, and socioeconomic disparities in retinoblastoma. JAMA Pediatr. 2015;169(12):1096–1104. doi:10.1001/jamapediatrics.2015.2360.
- Chiang MF, Sommer A, Rich WL, Lum F, Parke DW. The 2016 American academy of ophthalmology IRIS® registry (intelligent research in sight) database. Ophthalmology. 2018;125(8):1143–1148. doi:10.1016/j.ophtha.2017.12.001.
- van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6):681–694. doi:10.1002/(sici)1097-0258(19990330)18:6<681:aid-sim71>3.0.co;2-r.
- van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Soft. 2011;45(3). doi:10.18637/jss.v045.i03.
- Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112(6 Pt 1):1248–1255. doi:10.1542/peds.112.6.1248.
- Green AL, Chintagumpala M, Krailo M, et al. Correlation of insurance, race, and ethnicity with pathologic risk in a controlled retinoblastoma cohort: a children’s oncology group study. Ophthalmology. 2016;123(8):1817–1823. doi:10.1016/j.ophtha.2016.04.043.
- Belson PJ, Eastwood JA, Brecht ML, Hays RD, Pike NA. A review of literature on health-related quality of life of retinoblastoma survivors. J Pediatr Oncol Nurs. 2020;37(2):116–127. doi:10.1177/1043454219888805.
- Canturk S, Qaddoumi I, Khetan V, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94(11):1432–1436. doi:10.1136/bjo.2009.168062.
- Abramson DH, Daniels AB, Marr BP, et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS One. 2016;11(1):e0146582. doi:10.1371/journal.pone.0146582.
- Leiter A, Diefenbach MA, Doucette J, Oh WK, Galsky MD. Clinical trial awareness: changes over time and sociodemographic disparities. Clin Trials. 2015;12(3):215–223. doi:10.1177/1740774515571917.